Article | Open | Published:

Biogenic selenium and its hepatoprotective activity

Scientific Reportsvolume 7, Article number: 15627 (2017) | Download Citation

Subjects

Abstract

Elemental selenium nanoparticles (SeNPs) have multiple biological activities. In this study, we investigated the protective effects of biogenic SeNPs (BioSeNPs) on CCl4-induced liver damage in mice. The results showed that: (i) when compared to sodium selenite (SS), BioSeNPs has a similar tissue distribution after intragastrical administration to mice; (ii) BioSeNPs and SS showed comparable efficacy in increasing the activities of glutathione peroxidase and thioredoxin reductase in liver cell lines, mice blood and liver; (iii) pretreatment with BioSeNPs inhibiting the elevation of activities of various enzymes significantly which included aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase and liver lipid peroxide (p < 0.05 or p < 0.01) in CCl4-treated mice; (iv) activities of antioxidant enzymes (superoxide dismutase, catalase, and glutathione peroxidase) were significantly increased (p < 0.05 or p < 0.01) after a pretreatment with BioSeNPs in CCl4-treated mice; (v) histopathological damages in the liver from CCl4-treated mice were ameliorated by a pretreatment with BioSeNPs. In conclusion, these results have shown that BioSeNPs is able to protect the liver from CCl4-induced hepatic damage via increasing the antioxidant capacity and inhibiting oxidative damage. BioSeNPs may have the potential to be used as a trace element food supplement inducing antioxidant bioactivities.

Introduction

Selenium (Se), one of the essential trace elements, has multiple beneficial effects for human health, such as acting as antioxidant, prevention of cancer initiation, growths, and metastasis without toxic side effect1,2,3,4. However, the element and its derivates have different bioavailability and biological activities5,6. Among the various forms of Se, Se nanoparticles (SeNPs) are envisaged widely in biomedicine due to their high bioavailability and diverse biological activities7,8.

SeNPs can be synthesized through physical, chemical, and biological methods9,10. Se0 has been considered as biologically inactive until Zhang11 showed that, compared to sodium selenite (SS), chemically synthesized SeNPs (ch-SeNPs) were less toxic to cells and tissues, while maintaining similar antioxidant and bioavailability properties. In fact, in animal models, ch-SeNPs were proven to be effective antioxidants without notable cytotoxicity which is a typical side effect of other chemical forms of Se12. Therefore, SeNPs have attracted much attention to be used as potential nutrition supplementation7,9,13.

Nevertheless, the preparations of SeNPs using physical or chemical methods require high temperature, extreme pH, and harmful chemicals, which are proven to be very expensive and can cause environmental pullution14,15. Biogenic methods provide a renewable, clean, nontoxic, and environmentally friendly procedure for the synthesis of SeNPs10,16,17. Biological synthesized SeNPs (BioSeNPs) are known from bacteria, fungi, yeasts, and plants9,10,15,18. Among them, bacteria are the first choice for the biosynthesis of particles, because of their rapid extracellular production, ease and inexpensive culture, and ease of post-processing19. In recent years, several different bacteria have been reported to be capable of synthesizing SeNPs, such as Rhizobium selenitireducens strain B120, Escherichia coli 21, Pseudomonas fluorescens K2722, and Bacillus cereus 23. However, elemental Se particles produced by some bacterial strains have a very low bioavailability over extended periods of time24,25. BioSeNPs demonstrated antioxidant and anticancer activities in recent studies without mentioning its bioavailability in mice5,26,27.

Photosynthetic bacteria (PBS) are rich in protein, carotenoids, biological cofactors, and vitamins28. Studies have shown that PBS is suitable as a healthy food supplement for humans and animals15. Recently, our group reported that strain N of Rhodopseudomonas palustris (R. palustris), a typical purple non-sulfur bacterium, can reduce Se4+ to red elemental Se at room temperature under conventional culture conditions29. Thus, this bacterial strain provides a candidate supplement for the biosynthesis of SeNPs.

Carbon tetrachloride (CCl4) is a chemical agent that induces liver damage. CCl4 causes oxidative stress and lipid peroxidation by cytochrome P4502E1-mediated generation of high activity radicals, eventually leading to liver cell necrosis30. In recent years, the antioxidant and hepatoprotective activity of SeNPs have been reported. However, these reports focused on the study of SeNPs obtained from physicochemical synthesis12,31. The protective effect of BioSeNPs on liver damage has not been reported. Therefore, the purpose of our study is to verify that BioSeNPs is able to protect the liver from CCl4-induced hepatic damage via increasing the antioxidant capacity and inhibiting oxidative damage.

Here, we investigated the protective effect of BioSeNPs from strain N on CCl4-induced liver damage and the underlying mechanisms of this protection.

Results

Transformation of Se4+ to SeNPs

An electron micrograph of cells and Se-containing particles obtained from the culture medium was amended with 3.0 m mol/L SS is shown in Fig. 1A. Spherical SeNPs of various sizes had formed on the inside and the surface of R. palustris cells. The particle sizes ranged from 80 to 200 nm as shown in our previous publication29. Furthermore, Se-containing particles were analyzed by using energy dispersive X-ray spectrum (EDX) analysis, the electron-dense particles produced specific Se absorption peaks at 1.37 keV (peak SeLa), 11.22 keV (peak SeKa), and 12.49 keV (peak SeKb) (Fig. 1B). These results indicate that Se4+ was reduced to red elemental SeNPs by R. palustris.

Figure 1
Figure 1

Characterization of SR: (A) TEM micrographs, and (B) EDX spectrum of the particles.

Induction of Se-containing enzymes in HepG2 cells

In this study, we added 10, 20, and 50 nM SS and SeNPs-enriched R. palustris (SR) to compare their effect on inducing Se-containing enzymes in HepG2 cells. As shown in Fig. 2, the GSH-Px, and TrxR activities were significantly increased by SR or SS after 4 days of Se supplementation (p < 0.05) in a dose dependent manner. Pretreatment with the bacteria alone did not modify the activities of the enzymes.

Figure 2
Figure 2

Se-containing enzyme activities induced by SR and SS in HepG2 cells. Data show means ± SD (n = 3). ***Significantly difference compared to group1 (*p < 0.05, **p < 0.01).

Se accumulation in the tissue

Se accumulation in blood and liver occurs in enzymatic and non-enzymatic proteins as well as in inorganic ionic forms. After 7 days of Se supplementation, compared to those in the group1, the blood (Fig. 3A) and liver (Fig. 3B) samples from mice pretreated with SR or SS had significantly higher levels of Se (p < 0.05). In contrast, bacteria alone did not change the Se concentration of the tissues (Fig. 3A,B). There was no significant difference in Se accumulation between groups 5–7 and groups 8–10.

Figure 3
Figure 3

Se accumulation in mice supplemented with SR and SS: (A) Se in blood; (B) Se in liver. *Significantly difference compared to group1 (*p < 0.05).

Induction of Se-containing enzymes in mice

As shown in Fig. 4, glutathione peroxidase (GSH-Px) activities of blood (Fig. 4A) and liver (Fig. 4B) were significantly increased by SR or SS. Similar to the GSH-Px activity, the activities of thioredoxin reductase (TrxR) in mice blood (Fig. 4C) and liver (Fig. 4D) also showed a significant increase in the groups 5–7 and groups 8–10 after 7 days of Se supplementation (p < 0.05). Pretreatment with the bacteria alone did not modify the activities of the enzymes.

Figure 4
Figure 4

Se-containing enzymes in mice supplemented with SR and SS: (A) GSH-Px in blood; (B) GSH-Px in liver; (C) TrxR in blood; (D) TrxR in liver. *Significantly difference compared to group1 (*p < 0.05).

Effects of SR on hepatic function in CCl4-treated mice

Several hepatic enzymes in serum such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) were used as biochemical markers for early acute hepatic damage. The levels of ALT, AST, ALP, and LDH in the serum were measured. In comparison with group1, the CCl4-treated mice in group3 had higher levels of ALT (21062.51 ± 1217.47 U/L vs. 15.6 ± 2.14 U/L, p < 0.001), AST (3198.51 ± 313.323 U/L vs. 59.54 ± 5.51 U/L, p < 0.001), ALP (16.4 ± 0.26 U/L vs. 7.56 ± 0.32 U/L, p < 0.01), and LDH (649096.39 ± 9958 U/L vs. 19122.2 ± 1395.17 U/L, p < 0.001) (see Table 1). High dose of SR alone did not cause an elevation of the activities of serum ALT, AST, ALP, and LDH. As expected, this CCl4-induced increase was effectively attenuated by pretreatment with SR (p < 0.05 or p < 0.01) in a dose-dependent manner. Pretreatment with bacteria alone was unable to inhibit the increase in the enzymatic activities caused by CCl4 (Table 1).

Table 1 Effect of SR on serum enzyme activities in mice: ALT, AST, ALP, LDH.

Effects of SR on antioxidant enzyme activities in liver from CCl4-treated mice

The hepatic antioxidant enzyme activities [superoxide dismutase (SOD), catalase (CAT), and GSH-Px] were measured to investigate the effect of SR on the antioxidant capacity. The CCl4-treated mice in group 3, the activities of liver SOD, CAT, and GSH-Px were significantly decreased (p < 0.001) (Fig. 5A–C). However, high dose of SR alone did not cause a decrease of the activities of liver SOD, CAT, and GSH-Px. Pretreatment with SR, but not the bacteria alone, was able to significantly prevent the inhibition effects of CCl4 on the enzymes (p < 0.05 or p < 0.01), in a dose-dependent manner (Fig. 5A–C).

Figure 5
Figure 5

Effects of SR on the activities of liver SOD (A), CAT (B), GSH-Px (C), and the level of liver MDA (D) in CCl4-treated mice. ##, ###Significant differences compared to group1 (##p < 0.01, ###p < 0.001). *,**Significant differences compared to group3 (*p < 0.05, **p < 0.01).

Effects of SR on lipid peroxidation in liver tissue from CCl4-treated mice

Hepatic levels of malondialdehyde (MDA) were assessed as an indicator of lipid peroxidation in the tissue. In the group 3, MDA levels in liver were significantly increased (p < 0.001) in mice treated with CCl4 (Fig. 5D). However, high dose of SR alone did not cause an elevation of liver levels of MDA. Pretreatment with SR, at the medium-dose group and high-dose group, significantly prevented an increase in the levels of MDA (p < 0.05 or p < 0.01) in the mice treated with CCl4. In contrast, pretreatment with R. palustris alone did not prevent an increase in the MDA levels in the mice treated with CCl4.

Effects of SR on histopathological changes in CCl4-induced hepatotoxicity

In this study, the surface of liver in the control group was dark red, luster, and smooth, with tidy edges as revealed by stereo light microscopy (Fig. 6A). Mice pretreated with a high dose of SR alone did not cause abnormalities in the liver (Fig. 6B). When treated with CCl4 alone, the liver surface was grey, lacked lusters with irregular margins, and had bleeding spots in group3 (Fig. 6C). Pretreatment with SR attenuated the bleeding symptom substantially at all the tested concentrations (Fig. 6G–I), especially when the dosage increased to 200 µg Se/kg BW. Moreover, pretreatment with R. palustris did not attenuate the bleeding symptom substantially at all the tested concentrations (Fig. 6D–F).

Figure 6
Figure 6

Effects of SR on CCl4-induced liver damage. Liver tissues were observed under light microscopy. (A) group1; (B) group2; (C) group3; (D) group4; (E) group5; (F) group6; (G) group7; (H) group8; (I) group9.

When mice were treated with CCl4 in group 3, CCl4 caused extensive changes in liver morphology, including severe cellular degeneration, hepatocyte necrosis, and cytoplasm vacuolization (Fig. 7C). The hepatic cellular architecture of mice pretreated with a high dose of SR alone (Fig. 7B) was similar to those in the group 1 (Fig. 7A) with physiological saline. However, the histopathological damages in the liver from CCl4-treated mice were ameliorated by the pretreatment with SR in a dose-dependent manner (Fig. 7G–I); SR at 200 µg Se/kg BW was able to entirely block the tissue damages by CCl4, resulting in well-preserved cytoplasm, prominent nuclei and legible nucleoli (Fig. 7I). Pretreatment with the R. palustris did not show an effective protection against CCl4-induced liver damage (Fig. 7D–F).

Figure 7
Figure 7

Effects of SR on CCl4-induced liver damage. Sections were stained with haematoxylin-eosin and observed under light microscopy. (A) group1; (B) group2; (C) group3; (D) group4; (E) group5; (F) group6; (G) group7; (H) group8; (I) group9. 1: ballooning degeneration; 2: inflammatory cell infiltration; 3: cell necrosis.

Discussion

Absorption and utilization of Selenium in an organism is a prerequisite for its biological function. In 2004, Zhang et al. found that ch-SeNPs from 5 to 200 nm had similar efficacy compared to SS and had no size effect in the induction of seleno-enzymes in both cultured cells and mice. But, ch-SeNPs above 200 nm showed less absorption and utilization12,32. And, some reports have indicated that SeNPs about 300 nm obtained from bacteria has very low absorption and utilization compared to SS24,25,33. In our study, SeNPs from R. palustris range from 80–200 nm (Fig. 1A) had similar efficacy in Se accumulation and effects on GSH-Px as well as TrxR activity in both cultured cells and mice. Similar to ch-SeNPs, BioSeNPs may also have size effect in absorption and utilization.

Some studies have shown that different forms of selenium can increase GPx and TrxR activity in blood and liver11,12,32. Our results demonstrated that the SR improves the blood GSH-Px compared to SS, and GSH-Px levels were increased significantly by SS compared to SR in the liver. However, this trend was not observed for TrxR (Fig. 3). This may be due to the fact that GSH-Px activity changes with concentration effect and tissue differences34 and the activity of TrxR is no very much tissue specific35,36.

CCl4-induced liver injury is the best system of xenobiotic-induced hepatotoxicity and a commonly used model for the screening of liver protection drugs37,38. Liver damage induced by CCl4 is associated with severe lipid peroxidation, depletion of the antioxidant capacity, and damages to cell membranes as well as organelles39,40,41. In our study we showed for the first time that treatment with BioSeNPs from R. palustris can significantly prevent CCl4-induced acute liver damage (Fig. 4).

Serum enzymes, such as ALT, AST, ALP, and LDH are generally recognized as bio-chemical markers of liver injury, and they will exhibit increased activity when hepatocytes are necrotic42,43,44. The present study showed that the activities of ALT, AST, ALP, and LDH in group 3 were maximally increased 1350-, 43.7-, 2.2- and 33.9-fold compared to the activities in the group 1. The results suggested serious hepatocellular damage (Table 1). Supplementation of BioSeNPs significantly attenuated an increase in the enzymatic activities in the serum. Compared with group 3, the activities of ALT, AST, ALP, and LDH in the group 9 were decreased by 41.68%, 54.16%, 51.24% and 18.38%. Histopathological examination of the liver sections in CCl4-treated mice revealed extensive liver injuries, characterized by severe cellular degeneration, hepatocyte necrosis, and cytoplasmic vacuolization (Figs 6C and 7C). However, liver histopathological lesions were significantly ameliorated by the pretreatment with BioSeNPs, which was consistent with the results of the biochemical analysis (Figs 6G–I and 7G–I).

Hepatoprotective effects may be associated with an antioxidant capacity to scavenge reactive oxygen species (ROS)45. The intracellular redox balance depends on ROS production and antioxidant-defense system that includes enzymatic antioxidants such as SOD, CAT, and GSH-Px in cells30,46. Therefore, enzymatic antioxidant activities and the inhibition of free-radical generation are important in terms of protecting the liver from CCl4-induced damage30. To show the effect of BioSeNPs on oxidative stress-mediated hepatic injury, we have determined several oxidative stress indicators, including SOD, CAT, GSH-Px, and MDA. Consistent with reported results47, we found that supplementation of SeNPs from R. palustris could significantly increase the activities of SOD, CAT and GSH-Px and markedly decreased the MDA levels in the liver of CCl4-treated mice. The activities of SOD, CAT and GSH-Px in group 9 maximally increased 2.00-, 1.95-, and 2.03-fold. MDA levels decrease by 49.00% compared to group 3 (Fig. 5). This suggests that our BioSeNPs increased the antioxidant capacity of liver to counteract oxidative stress caused by CCl4.

In conclusion, our SeNPs from strain N of R. palustris had a similar efficacy in Se accumulation and Se-containing enzymes activities in both cultured cells and mice to SS. It showed no notable toxicity in vivo mice. Moreover, it can protect mice from CCl4-induced hepatic damage by increasing the antioxidant capacity to inhibit oxidative stress. The BioSeNPs can be developed as a food supplement for improving human body antioxidant capacity and preventing oxidative damage.

Methods

Preparation of SeNPs-enriched and control of R. palustris

R. palustris was cultured according to the method described by Li et al.29, except that the medium was supplemented with 3.0 m mol/L SS and the strain was incubated at 30 °C in the presence of incandescent light (1500 Lux) at gentle stirring (80 r/min) with magnetic stirrer for 8 days for SeNPs enrichment. Control samples were cultured without SS. During the culture, the Se4+ in SS was reduced to form red elemental Se. The bacteria were then collected by centrifugation at 5000 × g for 30 min at 4 °C, washed three times with sterile 0.9% saline solution, and stored at −4 °C until use for the animal study. Bacterial cells were resuspended in 2.5% glutaraldehyde and fixed for 2 h, washed with phosphate buffer (0.2 m mol/L, pH 7.0), and embedded in low-melting-point agarose. Agar blocks (approximately 1 by 1 by 1 mm) were fixed in 1% OsO4 in running water for 60 min, dehydrated with ethanol and acetone, and embedded in Epon-Araldite. Sections cut from the Epon-Araldite preparation were contrasted with uranyl acetate and lead citrate as described by Li29. The samples were examined using a JEM-1011 transmission electron microscope (JEOL, Tokyo, Japan) with an accelerating voltage of 80 kV. To determine the elemental composition of the nanoparticles, whole bacterial cells were applied to transmission electron microscopy grids, dried at room temperature, and coated with 5 nm of carbon before measurements were obtained. The EDX analysis was performed with a JEM-2010 transmission electron microscope (JEOL, Tokyo, Japan) equipped with a Link-Inca microanalysis system. The dwelling time for the EDX analysis was 100 s.


Cell Culture and Preparation of Cell Extracts

Human liver cancer HepG2 cells were purchased from Cell Bank of Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). HepG2 were maintained in DMEM medium supplemented with 10% fetal bovine serum, 1% L-glutamine, and 1% penicillin-streptomycin in a humidified incubator with 5% CO2 at 37 °C. For enzyme assays, cells were seeded in 10-cm dishes, and normally reached about 50% confluence at the time of Se-supplementation. Cells were treated with SR and SS from a prepared stock solution in PBS, added to the culture medium to obtain final concentrations indicated as in each experiment (in accordance with Table 2). Equivalent volumes of PBS were used as a vehicle. The doses of Se were chosen according to the report by zhang32. Cells were harvested after 4 days incubation with Se. Each treatment contained three replications. Adherent cells were washed twice with phosphate-buffered saline (PBS) and harvested using trypsin/EDTA. Cell extracts for measurement of enzyme activities were obtained by sonication in 0.1 M Tris-HCl at pH 7.4, containing 0.1% digitonin and then centrifuged at 15,000 g at 4 °C for 15 min to obtain supernatants. The activities of GSH-Px (Nanjing Jian Cheng, Nanjing, China) and TrxR (Beijing Solarbio, Beijing, China) in cell were estimated using their kits by spectrophotometry, according to the manufacturer’s instructions. Protein levels were determined by the Bradford assay with bovine serum albumin as a standard48.

Table 2 Activities of GSH-PX and TrxR in HepG2 cells (n = 3).

Animal model

All animal experiments were approved by the Institutional Committee from China Institute for Radiation Protection (Taiyuan, China) and comply with the Institute for Lab Animals’ guidelines for the humane care and use of laboratory animals. Se-deficient and normal male Kunming mice (body weight: 18–22 g) and low Se diet (<0.02 μg Se/g) were purchased from Shanxi Medical University Animal Centre (Taiyuan, China). The mice were kept in plastic cages (5/each), allowed free access to water and food, and maintained at a 12:12 h light and dark cycle during the study period. The temperature and humidity were regulated at 22 ± 1 °C and 50 ± 10%, respectively. The mice were acclimatized for 1 week before experimental to use.


Se accumulation and Se-containing enzymes in mice

The SR was re-suspended in 0.9% saline solution to obtain the desired bacterial cell concentrations of 8.438 × 108 CFU/ml. The content of total Se in the SR was 200.0 mg/L, with >99.60% being elemental SeNPs and 0.24% being organic Se, which were determined by hydride generation atomic absorption spectrometry (HG-AAS)25,49.

One hundred Se-deficient mice were randomly divided into the following ten groups with 10 mice per group (in accordance to Table 3). The doses of Se were chosen according to the report by Peng50. Mice were fed a Se-deficient diet (<0.02 μg Se/g diet) during the experimental phase of the study. All administrations were conducted at nine o’clock for 7 consecutive days. All the doses were administered once daily (0.3 ml, i.g). Animals were sacrificed at the end of the experimental period. Blood samples were collected from the ophthalmic veins. The livers were quickly excised and rinsed with ice-cold normal saline. After excessive moisture was removed, liver tissues were weighed and packed in centrifuge tubes. The collected liver and blood samples were stored at −80 °C until use.

Table 3 Experimental mice groups related to bioactivity.

Se concentrations in whole blood and liver were determined by HG-AAS as described previously49. Liver tissue was homogenized by an automatic homogenizer. During the preparation, 0.5 g of each hepatic tissue was homogenized in nine-fold (w/v) ice-cold saline, and centrifuged at 15,000 g for 15 min. The supernatant was used for Se quantification and enzymatic assays. The activities of GSH-Px (Nanjing Jian Cheng, Nanjing, China) and TrxR (Beijing Solarbio, Beijing, China) in whole blood and liver were estimated using assay kits by spectrophotometry, according to the manufacturer’s instructions. Protein levels were determined by the Bradford assay with bovine serum albumin as a standard48.


Protection against liver injury

Ninety mice were randomly divided into the following nine groups of 10 mice (in accordance to Table 4). The doses of Se were equivalent and according to that of Zhang51. All administrations were conducted at 9 o’clock in the morning for 14 consecutive days. All the doses were administered once daily (0.3 ml, i.g). On the fifteenth day, all the mice except the group1 and group2 received 0.3 ml of 1% CCl4/sunflower seed oil mixture (v/v) by intraperitoneal injection to induce acute hepatic injury, while the group1 and group2 received 0.3 ml of sunflower seed oil. After two hours, all the animals were fasted strictly, but drank water ad libitum as before. After CCl4 treatment (24 h), all animals were sacrificed to obtain blood and liver samples.

Table 4 Experimental mice groups show protection against liver injury.

Blood samples were collected from the ophthalmic veins of both eyes. The samples of blood were centrifuged at 1700 g for 30 min and supernatants were stored at 4 °C. The activities of AST, ALT, ALP, and LDH in serum were determined using commercial assay kits (Nanjing Jian Cheng, Nanjing, China), according to the manufacturer’s instructions. Livers were quickly excised, rinsed with ice-cold physiological saline, blotted with wet paper to remove excess moisture, and divided into two parts. The first part was homogenized in ice-cold physiological saline and centrifuged at 15,000 g at 4 °C for 15 min. The supernatant was used for biochemical assessments. The activities of GSH-Px, CAT, SOD and the levels of MDA in liver were measured using a commercial assay kit (Nanjing Jian Cheng, Nanjing, China). The second part of each liver [(1–2) mm × 5 mm × 10 mm] obtained from the left outer lobe of the organ was fixed in 10% buffered formaldehyde solution for histopathological examinations.

A conventional protocol52 was used for the histological examination of liver samples: livers were excised quickly and then fixed by direct immersion in a 0.1 M phosphate buffer (pH 7.4) with 4% paraformaldehyde for 24 h, dehydrated with a ethanol and toluene series, embedded in paraffin and sectioned as 4 μm-thick slices using a microtome (Leica RM2255, Solms, Germany). Five sections of each sample were stained with hematoxylin and eosin. Sections from the control and experimental samples were collected from similar tissue locations. Slides were examined with a light microscope (Olympus BX51, Tokyo, Japan).


Statistical analysis

All experiments were performed in triplicate and the results were expressed as means ± SD. Data were analyzed using one-way ANOVA (SPSS 17.0). A p < 0.05 was considered as statistically significant.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Rayman, M. P. Selenium and human health. Lancet 379, 1256–1268 (2012).

  2. 2.

    Wang, Y. et al. In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles. ACS Nano. 10, 9927–9937 (2016).

  3. 3.

    Wang, G. et al. Mitochondria-mediated protein regulation mechanism of polymorph-dependent inhibition of nanoselenium on cancer cells. Sci. Rep. 6, 31427, https://doi.org/10.1038/srep31427 (2016).

  4. 4.

    Bhattacharjee, A., Basu, A., Biswas, J., Sen, T. & Bhattacharya, S. Chemoprotective and chemosensitizing properties of selenium nanoparticle (Nano-Se) during adjuvant therapy with cyclophosphamide in tumor-bearing mice. Mol. Cell Biochem. 424, 13–33 (2017).

  5. 5.

    Forootanfar, H. et al. Antioxidant and cytotoxic effect of biologically synthesized selenium nanoparticles in comparison to selenium dioxide. J. Trace Elem. Med. Bio. 28, 75–79 (2014).

  6. 6.

    Shen, Q. et al. Antioxidant activity in vitro of the selenium-contained protein from the Se-enriched Bifidobacterium animalis 01. Anaerobe 16, 380–386 (2010).

  7. 7.

    Benko, I. et al. Subacute toxicity of nano-selenium compared to other selenium species in mice. Environ. Toxicol. Chem. 31, 2812–2820 (2012).

  8. 8.

    Deng, Y. et al. Preparation of elemental selenium-enriched fermented milk by newly isolated Lactobacillus brevis from kefir grains. Int. Dairy J. 44, 31–36 (2015).

  9. 9.

    Shirsat, S., Kadam, A., Naushad, M. & Mane, R. S. Selenium nanostructures: microbial synthesis and applications. RSC Adv. 5, 92799–92811 (2015).

  10. 10.

    Wadhwani, S. A., Shedbalkar, U. U., Singh, R. & Chopade, B. A. Biogenic selenium nanoparticles: current status and future prospects. Appl. Microbiol. Biotechnol. 100, 2555–2566 (2016).

  11. 11.

    Zhang, J. S., Gao, X. Y., Zhang, L. D. & Bao, Y. P. Biological effects of a nano red elemental selenium. Biofactors 15, 27–38 (2001).

  12. 12.

    Wang, H. L., Zhang, J. S. & Yu, H. Q. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: Comparison with selenomethionine in mice. Free Radic. Biol. Med. 42, 1524–1533 (2007).

  13. 13.

    Skalickova, S. et al. Selenium nanoparticles as a nutritional supplement. Nutrition 33, 83–90 (2017).

  14. 14.

    Iranifam, M. et al. A novel selenium nanoparticles-enhanced chemiluminescence system for determination of dinitrobutylphenol. Talanta 107, 263–269 (2013).

  15. 15.

    Paulraj, S. & Kumar, M. S. Selenium bioavailability through microbes in Biofortification of Food Crops (eds Singh, U. et al.) Ch. 8, 303-316 (Springer, 2016).

  16. 16.

    Singh, R., Shedbalkar, U. U., Wadhwani, S. A. & Chopade, B. A. Bacteriagenic silver nanoparticles: synthesis, mechanism, and applications. Appl. Microbiol. Biotechnol. 99, 4579–4593 (2015).

  17. 17.

    Avendano, R. et al. Production of selenium nanoparticles in Pseudomonas putida KT2440. Sci. Rep. 6, 37155, https://doi.org/10.1038/srep37155 (2016).

  18. 18.

    Bao, P. et al. Characterization and potential applications of a selenium nanoparticle producing and nitrate reducing bacterium Bacillus oryziterrae sp. nov. Sci. Rep. 6, 34054, https://doi.org/10.1038/srep34054 (2016).

  19. 19.

    Ramanathan, R. et al. Aqueous phase synthesis of copper nanoparticles: a link between heavy metal resistance and nanoparticle synthesis ability in bacterial systems. Nanoscale 5, 2300–2306 (2013).

  20. 20.

    Hunter, W. J., Kuykendall, L. D. & Manter, D. K. Rhizobium selenireducens sp. nov.: a selenite reducing α-Proteobacteria isolated from a bioreactor. Curr. Microbiol. 55, 455–460 (2007).

  21. 21.

    Avazeri, C. et al. Tellurite and selenate reductase activity of nitrate reductases from Escherichia coli: correlation with tellurite resistance. Microbiology 143, 1181–1189 (1997).

  22. 22.

    Hapuarachchi, S., Swearingen, J. & Chasteen, T. G. Determination of elemental and precipitated selenium production by a facultative anaerobe grown under sequential anaerobic/aerobic conditions. Process Biochem. 39, 1607–1613 (2004).

  23. 23.

    Dhanjal, S. & Cameotra, S. S. Aerobic biogenesis of selenium nanospheres by Bacillus cereus isolated from coalmine soil. Microb. Cell Factories 9, 52–66 (2010).

  24. 24.

    Schlekat, C. E., Dowdle, P. R., Lee, B. G., Luoma, S. N. & Oremland, R. S. Bioavailability of particle-associated Se to the bivalve Potamocorbula amurensis. Environ. Sci. Technol. 34, 4504–4510 (2000).

  25. 25.

    Combs, G. F. et al. Bioavailability of selenium accumulated by selenite-reducing bacteria. Biol. Trace Elem. Res. 52, 209–225 (1996).

  26. 26.

    Shirsat, S. et al. Protective role of biogenic selenium nanoparticles in immunological and oxidative stress generated by enrofloxacin in broiler chicken. Dalton Trans. 45, 8845–53 (2016).

  27. 27.

    Ahmad, M. S., Yasser, M. M., Sholkamy, E. N., Ali, A. M. & Mehanni, M. M. Anticancer activity of biostabilized selenium nanorods synthesized by Streptomyces bikiniensis strain Ess_amA-1. Int. J. Nanomedicine. 10, 3389–3401 (2015).

  28. 28.

    Kobayashi, M. & Kurata, S. The mass culture and cell utilization of photosynthetic bacteria. Process Biochem. 13, 27–30 (1978).

  29. 29.

    Li, B. Z. et al. Reduction of selenite to red elemental selenium by Rhodopseudomonas palustris strain N. PLOS ONE 9, e95955, https://doi.org/10.1371/journal. pone.0095955 (2014).

  30. 30.

    Huang, G. J. et al. Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury. Food Chem. 141, 3020–3027 (2013).

  31. 31.

    Zhang, B. J. & Li, X. Y. Protective effects of selenium nanoparticles on oxidative stress and antioxidant enzymes activities induced by microcystins in the liver of mice. Acta Hydrobiologica Sinica. 34, 679–683 (2010).

  32. 32.

    Zhang, J. S., Wang, H. L., Bao, Y. P. & Zhang, L. D. Nano red elemental selenium has no size effect in the induction of seleno-enzymes in both cultured cells and mice. Life Sci. 75, 237–244 (2004).

  33. 33.

    Garbisu, C., Ishii, T., Leighton, T. & Buchanan, B. B. Bacterial reduction of selenite to elemental selenium. Chem. Geol. 132, 199–204 (1996).

  34. 34.

    Behne, D. & Kyriakopoulos, A. Mammalian selenium-containing proteins. Annu. Rev. Nutr. 21, 453–473 (2001).

  35. 35.

    Behne, D. & Kyriakopoulos, A. Effects of dietary selenium on the tissue concentrations of type I iodothyronine 5′-deiodinase and other selenoproteins. Am. J.Clin. Nutr. 57, 310S–312S (1993).

  36. 36.

    Berry, M. J. Insights into the hierarchy of selenium incorporation. Nat. Genet. 37, 1162–1163 (2005).

  37. 37.

    Tian, L. M. et al. Chemical composition and hepatoprotective effects of polyphenol-rich extract from Houttuynia cordata tea. J. Agric. Food Chem. 60, 4641–4648 (2012).

  38. 38.

    Srivastava, A. & Shivanandappa, T. Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats. Food Chem. 118, 411–417 (2010).

  39. 39.

    Karakus, E. et al. Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4). J. Hazard Mater 195, 208–213 (2011).

  40. 40.

    Xu, J. Y. et al. Protective effects of fullerenol on carbon tetrachloride-induced acute hepatotoxicity and nephrotoxicity in rats. Carbon 48, 1388–1396 (2010).

  41. 41.

    Lu, X. S., Zhao, Y., Sun, Y. F., Yang, S. & Yang, X. B. Characterisation of polysaccharides from green tea of Huangshan Maofeng with antioxidant and hepatoprotective effects. Food Chem. 141, 3415–3423 (2013).

  42. 42.

    Tang, X. et al. Effective protection of Terminalia catappa L. leaves from damage induced by carbon tetrachloride in liver mitochondria. J. Nutr. Biochem. 17, 177–182 (2006).

  43. 43.

    Gencel, O., Naziroglu, M., Celik, O., Yalman, K. & Bayram, D. Selenium and vitamin E modulates radiation-induced liver toxicity in pregnant and nonpregnant rat: effects of colemanite and hematite shielding. Biol. Trace Elem. Res. 135, 253–263 (2010).

  44. 44.

    Subramanian, L. & Selvam, R. Prevention of CCl4 induced hepatotoxicity by aqueous extract of turmeric. Nutr. Res. 3, 429–441 (1999).

  45. 45.

    Parola, M. & Robino, G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 35, 297–306 (2001).

  46. 46.

    Mohammadi, M. & Yazdanparast, R. Methoxy VO-salen complex: In vitro antioxidant activity, cytotoxicity evaluation and protective effect on CCl4-induced oxidative stress in rats. Food Chem. Toxicol. 47, 716–721 (2009).

  47. 47.

    Liu, Y. H. et al. Protective effects of selenium-enriched probiotics on carbon tetrachloride-induced liver fibrosis in rats. J. Agric. Food Chem. 63, 242–249 (2015).

  48. 48.

    Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976).

  49. 49.

    Zhang, Y. Q., Frankenberger, W. T. & Moore, J. N. Measurement of selenite in sediment extracts by using hydride generation atomic absorption spectrometry. Sci. Total. Environ. 229, 183–193 (1999).

  50. 50.

    Peng, D., Zhang, J. S. & Liu, Q. L. Effect of sodium selenosulfate on restoring activities of selenium-dependent enzymes and selenium retention compared with sodium selenite in vitro and in vivo. Biol.Trace Elem.Res. 117, 77–88 (2007).

  51. 51.

    Zhang, J. S., Gao, X. Y., Zhang, L. D., Zhu, M. X. & Yang, Z. H. Study on liver protection, tumor inhibition and immune regulation of red elemental selenium. Acta Nutr. Sin. 23, 32–35 (2001).

  52. 52.

    Li, N. et al. Lead accumulation, oxidative damage and histopathological alteration in testes and accessory glands of freshwater crab, Sinopotamon henanense, induced by acute lead exposure. Ecotox. Environ. Safe. 11, 720–727 (2015).

Download references

Acknowledgements

The authors are grateful to Prof. Jiang-shiou Hwang and Prof. Li-Chun Tseng for their constructive comments on the manuscript. The authors are thankful to the scientific instrument center of Shanxi University for the TEM-EDX measurements. This work was supported by a Specialized Research Fund for the Doctoral Program (No. 20111401110010), the National Natural Science Foundation of China (No. 31272319) to Lan Wang and the Hundred Talent Project of Shanxi Province in 2013 to Hans-Uwe Dahms, Characteristic Key Discipline Construction Projects of Ordinary University in Shanxi Province (No. 2011-SXDX-SWX-003) and partly supported by a grant from Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Author information

Author notes

  1. Baozhen Li and Dan Li contributed equally to this work.

Affiliations

  1. School of Life Science, Shanxi University, Taiyuan, 030006, People’s Republic of China

    • Baozhen Li
    • , Dan Li
    • , Weixin Jing
    • , Jinhua Fan
    • , Shao-Chin Lee
    •  & Lan Wang
  2. Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan

    • Hans-Uwe Dahms
  3. Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan

    • Hans-Uwe Dahms

Authors

  1. Search for Baozhen Li in:

  2. Search for Dan Li in:

  3. Search for Weixin Jing in:

  4. Search for Jinhua Fan in:

  5. Search for Hans-Uwe Dahms in:

  6. Search for Shao-Chin Lee in:

  7. Search for Lan Wang in:

Contributions

B.L. and L.W. wrote the main manuscript. B.L. and J.F. performed in the bioactivity study and analyzed data. D.L., B.L., and W.J. performed in protective effects on CCl4-induced liver damage and analyzed data. S.L. and H.U.D. wrote and reviewed the manuscript. B.L. and D.L. equally contributed to this work.

Competing Interests

The authors declare that they have no competing interests.

Corresponding authors

Correspondence to Shao-Chin Lee or Lan Wang.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41598-017-13636-1

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.